Kiromic BioPharma (KRBP) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$2.60

+0.10 (+4.00%)

(As of 05:38 PM ET)

Source

Source	Headline
	Kiromic BioPharma files to withdraw registration statement msn.com - April 10 at 8:13 PM
	Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial businesswire.com - April 2 at 8:18 AM
	Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial finance.yahoo.com - March 19 at 11:21 AM
	Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial businesswire.com - March 19 at 8:08 AM
	Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial businesswire.com - March 1 at 8:08 AM
	Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th finance.yahoo.com - February 28 at 8:23 PM
	Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th businesswire.com - February 28 at 6:30 PM
	Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months finance.yahoo.com - February 14 at 10:24 AM
	Results from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months businesswire.com - February 14 at 8:08 AM
	Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer finance.yahoo.com - January 29 at 9:51 AM
	Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial finance.yahoo.com - January 5 at 10:07 AM
	Kiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung Cancer finance.yahoo.com - December 14 at 9:19 AM
	Kiromic BioPharma Announces Uplisting to OTCQB Market finance.yahoo.com - November 16 at 5:31 PM
	Kiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center finance.yahoo.com - November 9 at 10:17 AM
	Kiromic BioPharma Inc Ordinary Shares morningstar.com - November 1 at 8:36 PM
	Kiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial Agreement finance.yahoo.com - October 23 at 8:55 AM
	Staidson Beijing Biopharma (300204) uk.investing.com - September 15 at 9:22 PM
	Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14 finance.yahoo.com - September 13 at 7:00 PM
	Kiromic BioPharma Welcomes Two New Directors to its Board finance.yahoo.com - July 24 at 3:55 PM
	marketbeat.com - July 12 at 9:59 AM
	marketbeat.com - July 12 at 9:49 AM
	Kiromic Biopharma Shares Down 12% After Stock Offering Prospectus marketwatch.com - June 30 at 2:18 PM
	Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round bizjournals.com - June 10 at 11:45 PM
	KRBP - Kiromic BioPharma, Inc. finance.yahoo.com - June 10 at 1:42 PM
	Instrument Name Kiromic Biopharma Inc Instrument Symbol (KRBP-Q) theglobeandmail.com - June 8 at 7:49 AM
	marketbeat.com - May 22 at 12:50 PM
	marketbeat.com - May 10 at 1:13 PM
	marketbeat.com - May 8 at 3:15 PM
	marketbeat.com - May 8 at 2:15 PM
	marketbeat.com - May 4 at 11:10 AM
	What's Going On With Kiromic BioPharma Stock Wednesday finance.yahoo.com - May 3 at 7:03 PM
	marketbeat.com - May 3 at 3:14 PM
	marketbeat.com - May 3 at 11:38 AM
	marketbeat.com - May 3 at 11:25 AM
	marketbeat.com - May 3 at 10:52 AM
	marketbeat.com - May 3 at 10:44 AM
	marketbeat.com - May 3 at 10:41 AM
	marketbeat.com - May 3 at 10:28 AM
	marketbeat.com - May 3 at 10:19 AM
	marketbeat.com - May 3 at 9:43 AM
	Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer finance.yahoo.com - May 1 at 1:04 PM
	marketbeat.com - April 17 at 9:39 AM
	marketbeat.com - April 13 at 10:43 AM
	Kiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung Cancer finance.yahoo.com - April 3 at 9:39 AM
	marketbeat.com - March 31 at 10:28 AM
	Kiromic BioPharma Announces Reverse Stock Split finance.yahoo.com - March 10 at 8:40 PM
	Kiromic BioPharma Reports Favorable Deltacel™ Preclinical Pharmacology Results finance.yahoo.com - February 28 at 9:28 AM
	Two Leading Independent Proxy Advisory Firms Recommend Kiromic BioPharma Stockholders Vote "FOR" All Proxy Proposals finance.yahoo.com - February 23 at 5:24 PM
	Kiromic BioPharma CEO encourages stock split, sees Deltacel trial in 2Q23 msn.com - February 16 at 4:55 PM
	Kiromic BioPharma CEO Issues Letter to Stockholders finance.yahoo.com - February 16 at 11:55 AM

Get Kiromic BioPharma News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

KRBP Media Mentions By Week

KRBP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRBP
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

KRBP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRBP Articles
This Week
▼
0

0
▲
KRBP Articles
Average Week

Get Kiromic BioPharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:KRBP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Kiromic BioPharma (KRBP) News Today

KRBP Media Mentions By Week

KRBP Media Sentiment

KRBP News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info